The National Coordinator of CMU chaired the M&E and Surveillance Unit review meeting, emphasizing updates across all disease areas. Special attention was given to tracking progress within DHIS2 Tracker data. The agenda centered on assessing unit activities for HIV, Hepatitis, and TB, ensuring effective disease monitoring and evaluation strategies.
